Serhat TUNAR -TDO- An advisory board of the United States Food and Drug Administration (FDA) has approved the use of the Covid-19 vaccine, developed by Pfizer, in an emergency. The vaccination process in the United States is expected to begin shortly after the FDA approves the use of the vaccine.
The FDA advisory board met yesterday morning to consider Pfizer's application for approval. At the meeting, which was also broadcast live on Youtube, the Advisory Board of independent experts listened to various presentations.
By the day of the meeting, the advisory board had examined raw data from research on Pfizer's vaccine, and detailed analyses published earlier in the week indicated that the vaccine met the success criteria.